The use of AI in life sciences is growing fast, but is it really delivering on its promises? From internal process optimisation to strategic partnerships with AI-driven solution providers, this session will explore how companies are integrating AI into their innovation pipelines, relying on concrete use cases where AI has delivered value across clinical trial design, data analysis, decision-making. Experts will share the lessons learned from the frontlines of AI adoption, including both breakthroughs and missteps. What distinguishes hype from real value? How do companies now envision collaborations with AI providers, rather than or in complement with internal development? What do investors expect from AI-driven innovation? With regulatory and cultural shifts underway, what should the sector prepare for next?
Christian Hoffmann
Director of the Swiss AI Startup Center
University of Zurich
